• The University of Western Australia (M503), 35 Stirling Highway,

    6009 Perth


Calculated based on number of publications stored in Pure and citations from Scopus

Personal profile


I am the Head of the Biomarkers and Discovery unit of the NHMRC Centre for Research Excellence, The National Centre for Asbestos Related Disease, and manager of the NCARD Biobank.

I completed my undergraduate degree at the University of Western Australia and received my PhD in 1995 from La Trobe University (Melbourne, Australia). I was awarded a Howard Hughes Medical Institute Postdoctoral Fellowship and worked at the University of Cincinnati Medical Centre in Ohio, USA for three years.  I returned in 1999 to Australia to work with Professor Bruce Robinson and have worked in the cancer and immunology fields as a molecular biologist and protein chemist since.

Research interests

Biomarker discovery and validation

Neoantigen targeted immunotherapy for mesothelioma and lung cancer



Biomarker discovery and validation

My research focuses on identifying and validating new biomarkers for mesothelioma and lung cancer. Through extensive characterisation of the tumour genetic, epigenetic, protein and metabolite profile we are working towards improving early detection, diagnosis and prognosis for these deadly tumours, as well as predicting which patients will respond to treatment. In international collaborations, including with The Cancer Genome Atlas we have been involved in the identification of new biomarkers, tumour subtypes and diagnostic strategies for mesothelioma.


Neoantigen targeted immunotherapy for mesothelioma and lung cancer

My team is working towards developing a new personalised treatment approach for cancer through neoantigen targeting. Neoantigens arise from mutations in the DNA of cancerous cells. Through genetic and proteomic characterisation of tumours and sophisticated immunological predications neoantigens can be identified.  My team's work identified the first natural carcinogen induced neoantigen and has provided key new insights into the interplay between tumours, neoantigens and the immune system.



NCARD Biobank, largest collection of clinical specimens from patients with pleural disease focussing on mesothelioma, lung cancer and benign asbestos related disease. The bank includes tumour tissue, pleural effusions, blood and urine with extensive clinical annotation.   

Funding overview

My team has received funding from the National Health and Medical Research Council’s through the Centre of Research Excellence Programme, Enabling Grant and Project Grant schemes, as well as WA Cancer Council, iCARE, the Insurance Commission of WA and the Department of Health (WA).

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 2 - Zero Hunger
  • SDG 3 - Good Health and Well-being

Research expertise keywords

  • Mesothelioma
  • Lung Cancer
  • Biomarkers
  • Cancer immunology
  • Cancer biology
  • Biobanking


Dive into the research topics where Jenette Creaney is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or